William L. Carroll

Active 1986–2025

153
Papers
29,948
Citations
93
h-index
153
i10-index

Citations

Citations per year for William L. Carroll1987: 4 citations1988: 6 citations1989: 1 citations1991: 3 citations1992: 8 citations1993: 6 citations1994: 9 citations1995: 9 citations1996: 7 citations1997: 8 citations1998: 6 citations1999: 2 citations2000: 5 citations2001: 3 citations2002: 3 citations2003: 14 citations2004: 9 citations2005: 13 citations2006: 12 citations2007: 9 citations2008: 37 citations2009: 98 citations2010: 136 citations2011: 131 citations2012: 370 citations2013: 316 citations2014: 301 citations2015: 472 citations2016: 353 citations2017: 314 citations2018: 307 citations2019: 1,017 citations2020: 1,207 citations2021: 1,178 citations2022: 836 citations2023: 544 citations2024: 960 citations2025: 351 citations2026: 6 citations1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,398 citing papers, 28.3% of this breakdownChina: 635 citing papers, 7.5% of this breakdownGermany: 533 citing papers, 6.3% of this breakdownUnited Kingdom: 490 citing papers, 5.8% of this breakdownItaly: 442 citing papers, 5.2% of this breakdownNetherlands: 330 citing papers, 3.9% of this breakdownCanada: 305 citing papers, 3.6% of this breakdownFrance: 298 citing papers, 3.5% of this breakdownAustralia: 255 citing papers, 3% of this breakdownSpain: 191 citing papers, 2.2% of this breakdownJapan: 179 citing papers, 2.1% of this breakdownSweden: 167 citing papers, 2% of this breakdown
0%28.3%Other 26.6%

Fields

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology18.9%
  • Immunology and Microbiology3.5%
  • Computer Science0.6%
  • Neuroscience0.6%
  • Pharmacology, Toxicology and Pharmaceutics0.4%
  • Other1.8%

Topics

  • Acute Lymphoblastic Leukemia research15.9%
  • Childhood Cancer Survivors' Quality of Life7.7%
  • Acute Myeloid Leukemia Research7.2%
  • Chronic Myeloid Leukemia Treatments4.7%
  • CAR-T cell therapy research3.6%
  • Lymphoma Diagnosis and Treatment2.7%
  • Other58.2%

Coauthors

All papers

Open in search
  1. The genomic landscape of pediatric acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott G. Foy, Dale J. Hedges, Scott Newman, Xin Zhou, Jian Wang, Colleen Reilly, Edgar Sioson, Stephen V. Rice, Victor Pastor Loyola, Gang Wu, Evadnie Rampersaud, Shalini C. Reshmi, Julie M. Gastier-Foster, Jaime M. Guidry Auvil, Patee Gesuwan, Malcolm A. Smith, Naomi Winick, Andrew J. Carroll, Nyla A. Heerema, Richard C. Harvey, Cheryl L. Willman, Eric Larsen, Elizabeth A. Raetz, Michael J. Borowitz, Brent L. Wood, William L. Carroll, Patrick A. Zweidler‐McKay, Karen R. Rabin, Leonard A. Mattano, Kelly W. Maloney, Stuart S. Winter, Michael J. Burke, Wanda L. Salzer, Kimberly P. Dunsmore, Anne Angiolillo, Kristine R. Crews, James R. Downing, Sima Jeha, Ching‐Hon Pui, William E. Evans, Jun J. Yang, Mary V. Relling, Daniela S. Gerhard, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2022 cited by 397

  2. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Stuart S. Winter, Brent L. Wood, Brian P. Sorrentino, James R. Downing, Mignon L. Loh, Stephen P. Hunger, Jinghui Zhang, Charles G. Mullighan - Nature Genetics 2017 cited by 934

  3. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly W. Maloney, Alessandro Rambaldi, Orietta Spinelli, Jerald P. Radich, Mark D. Minden, Jacob M. Rowe, Selina M. Luger, Mark R. Litzow, Martin S. Tallman, Janis Racevskis, Yanming Zhang, Ravi Bhatia, Jessica Kohlschmidt, Krzysztof Mrózek, Clara D. Bloomfield, Wendy Stock, Steven M. Kornblau, Hagop M. Kantarjian, Marina Konopleva, Williams E. Evans, Sima Jeha, Ching‐Hon Pui, Jun J. Yang, Elisabeth Paietta, James R. Downing, Mary V. Relling, Jinghui Zhang, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan - Nature Genetics 2019 cited by 617

  4. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Cancer 2022 cited by 146

  5. Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Panduka Nagahawatte, Gang Wu, Xiang Chen, Donald Yergeau, Bhavin Vadodaria, Heather L. Mulder, Naomi Winick, Eric Larsen, William L. Carroll, Nyla A. Heerema, Andrew J. Carroll, Guy H. Grayson, Sarah K. Tasian, Andrew S. Moore, Frank Keller, Melissa Frei‐Jones, James A. Whitlock, Elizabeth A. Raetz, Deborah L. White, Timothy P. Hughes, Jaime M. Guidry Auvil, Malcolm A. Smith, Guido Marcucci, Clara D. Bloomfield, Krzysztof Mrózek, Jessica Kohlschmidt, Wendy Stock, Steven M. Kornblau, Marina Konopleva, Elisabeth Paietta, Ching‐Hon Pui, Sima Jeha, Mary V. Relling, William E. Evans, Daniela S. Gerhard, Julie M. Gastier-Foster, Elaine R. Mardis, Richard K. Wilson, Mignon L. Loh, James R. Downing, Stephen P. Hunger, Cheryl L. Willman, Jinghui Zhang, Charles G. Mullighan - New England Journal of Medicine 2014 cited by 1,376

  6. Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 1,444

  7. Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    Authors: , , , , , , , - Journal of Clinical Oncology 2012 cited by 1,191

  8. Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2020 cited by 194

  9. Five-Membered Ring Peroxide Selectively Initiates Ferroptosis in Cancer Cells

    Authors: , , - ACS Chemical Biology 2016 cited by 180

  10. Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

    Authors: , , , , , , , , , , - Leukemia 2008 cited by 581

  11. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 435

  12. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0331

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 198

  13. Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 255

  14. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 cited by 380

  15. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kimberly P. Dunsmore, Hiroto Inaba, William L. Carroll, Nilsa C. Ramirez, Aaron H. Phillips, Richard W. Kriwacki, Jun J. Yang, Tiffaney L. Vincent, Yaqi Zhao, Pankaj S. Ghate, Jian Wang, Colleen Reilly, Xin Zhou, Mathijs A. Sanders, Junko Takita, Motohiro Kato, Nao Takasugi, Bill H. Chang, Richard D. Press, Mignon L. Loh, Evadnie Rampersaud, Elizabeth A. Raetz, Stephen P. Hunger, Kai Tan, Ti‐Cheng Chang, Gang Wu, Stanley Pounds, Charles G. Mullighan, David T. Teachey - Nature 2024 cited by 137

  16. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

    Authors: , , , , , , , , , , , , , , , - Blood 2023 cited by 58

  17. Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , - Blood 2018 cited by 227

  18. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children’s Oncology Group AALL0434 Methotrexate Randomization

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 cited by 237

  19. Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross L. Levine, Guillermo Garcia‐Manero, Eric Larsen, Neil P. Shah, Meenakshi Devidas, Gregory H. Reaman, Malcolm A. Smith, Steven W. Paugh, William E. Evans, Stephan A. Grupp, Sima Jeha, Ching‐Hon Pui, Daniela S. Gerhard, J R Downing, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Marco A. Marra, Charles G. Mullighan - Cancer Cell 2012 cited by 718

  20. Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update

    Authors: , , , - Journal of Clinical Oncology 2011 cited by 837

  21. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

    Authors: , , , , , , , , , , , , - Blood 2008 cited by 835

  22. Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031

    Authors: , , , , , , , , , , , , , , , , , , , - Leukemia 2014 cited by 449

  23. Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Deepa Bhojwani, Ching‐Hon Pui, William E. Evans, Mary V. Relling, Stephen P. Hunger, Cheryl L. Willman, Charles G. Mullighan, Jun J. Yang - Nature Genetics 2013 cited by 308

  24. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Authors: , , , , , , , , , , , , , , , , , - Blood 2010 cited by 574